Business
Abu Dhabi’s Novel Foods to build $500m biotech production hub

Phoebe Fraser
8 March 2024
8 March 2024
Abu Dhabi’s Novel Foods to build $500m biotech production hub

Abu Dhabi-based company Novel Foods Group has announced plans to build a new $500 million biotech production hub in the United Arab Emirates.
The hub, which will focus on producing sweet proteins via precision fermentation, is part of a deal signed between Novel Foods, Glatt Group, BioEngineering and CB Consultancy during the inaugural Healthy Innovation Conference held recently in Dubai.
The new biotech production site will focus on the development of brazzein, a natural sweet protein with a sugary taste that is said to be several thousand times sweeter than sucrose.
The commercial applications of brazzein extend across various sectors, including beverages, confectionery, bakery, dairy and ice cream.
Brazzein is currently derived from berries of the equatorial belt of West Africa and has been consumed locally for centuries. Challenges in harvesting due to remote locations and limited availability are now being addressed through precision fermentation.
Alaa Al Ali, shareholder and member of the board of Novel Foods Group, said: "We believe people should enjoy the sweetness they love without sacrificing health or taste."
Novel Foods’ existing concept and R&D centre in Dubai is committed to crafting tailor-made recipes that replace sugar with brazzein, supporting co-creation with regional decision-makers and product development teams.
#NovelFoodsGroup #AbuDhabi #UAE
Related news
UK government urged to invest £150m in alternative protein innovation
The Good Food Institute Europe (GFI Europe) is calling on the UK government to bolster its commitment to alternative proteins by investing £150 million as part of the National Food Strategy.
Climax Foods rebrands to Bettani Farms, announces new CEO and $6.5m funding raise
Alt-dairy start-up Climax Foods has rebranded to Bettani Farms; has appointed former Califia Farms CFO, Sandeep Patel, as CEO and chairman; and has raised $6.5 million in Series A funding.
The Better Meat Co raises $31m to scale mycoprotein fermentation
The Better Meat Co (BMC) has secured $31 million in an oversubscribed Series A funding round to expand its patented mycoprotein fermentation technology to commercial scale.
Business
Abu Dhabi’s Novel Foods to build $500m biotech production hub

Phoebe Fraser
8 March 2024



